On Friday, Co-Diagnostics Inc (NASDAQ: CODX) was -11.28% drop from the session before settling in for the closing price of $0.29. A 52-week range for CODX has been $0.23 – $2.23.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 29.07%. When this article was written, the company’s average yearly earnings per share was at 13.71%. With a float of $30.68 million, this company’s outstanding shares have now reached $33.57 million.
Let’s determine the extent of company efficiency that accounts for 132 employees. In terms of profitability, gross margin is -12.25%, operating margin of -4079.44%, and the pretax margin is -3574.77%.
Co-Diagnostics Inc (CODX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Co-Diagnostics Inc stocks. The insider ownership of Co-Diagnostics Inc is 9.00%, while institutional ownership is 17.35%.
Co-Diagnostics Inc (CODX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 13.71% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.69% during the next five years compared to -27.40% drop over the previous five years of trading.
Co-Diagnostics Inc (NASDAQ: CODX) Trading Performance Indicators
You can see what Co-Diagnostics Inc (CODX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.23. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.14, a number that is poised to hit -0.62 in the next quarter and is forecasted to reach -0.42 in one year’s time.
Technical Analysis of Co-Diagnostics Inc (CODX)
Looking closely at Co-Diagnostics Inc (NASDAQ: CODX), its last 5-days average volume was 0.68 million, which is a jump from its year-to-date volume of 0.29 million. As of the previous 9 days, the stock’s Stochastic %D was 37.56%. Additionally, its Average True Range was 0.05.
During the past 100 days, Co-Diagnostics Inc’s (CODX) raw stochastic average was set at 3.32%, which indicates a significant decrease from 10.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 113.48% in the past 14 days, which was higher than the 99.87% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3413, while its 200-day Moving Average is $0.8255. However, in the short run, Co-Diagnostics Inc’s stock first resistance to watch stands at $0.3103. Second resistance stands at $0.3652. The third major resistance level sits at $0.3953. If the price goes on to break the first support level at $0.2253, it is likely to go to the next support level at $0.1952. Should the price break the second support level, the third support level stands at $0.1403.
Co-Diagnostics Inc (NASDAQ: CODX) Key Stats
There are 33,573K outstanding shares of the company, which has a market capitalization of 8.61 million. As of now, sales total 3,920 K while income totals -37,640 K. Its latest quarter income was 50 K while its last quarter net income were -7,530 K.
